Indeed we observed an inverse correlation between BAFF levels and IgG positivity against EBNA1400–413, MAP_0106c121–132, and BOLF1305–320, MAP_402718–32 peptides in MS patients with and without Methylprednisolone therapy. This evidence concerns the gene TNFSF13B and myeloid sarcoma.